Q'Apel Medical Announces CE Mark Approval for Armadillo SelectFlex™ Neurovascular Access System

Q'Apel Medical Inc. California

Patented SelectFlex™ Technology allows operators to achieve the ideal balance of trackability and support on demand to navigate complex neurovasculatureSystem enables biaxial approach, regardless of access site, to eliminate complexity and cost of conventional con?gurationsView original content:https://www.prnewswire.co.uk/news-releases/qapel-medical-announces-ce-mark-approval-for-armadillo-selectflex-neurovascular-access-system-302349303.html